nupharm laboratories limited
nupharm laboratories limited Company Information
Company Number
04123795
Next Accounts
Mar 2025
Shareholders
nupharm group ltd
Group Structure
View All
Industry
Manufacture of basic pharmaceutical products
+1Registered Address
bulman house regent centre, gosforth, newcastle upon tyne, NE3 3LS
Website
nupharmlabs.comnupharm laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of NUPHARM LABORATORIES LIMITED at £3.1m based on a Turnover of £2.5m and 1.22x industry multiple (adjusted for size and gross margin).
nupharm laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of NUPHARM LABORATORIES LIMITED at £0 based on an EBITDA of £-3.1m and a 5.19x industry multiple (adjusted for size and gross margin).
nupharm laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of NUPHARM LABORATORIES LIMITED at £0 based on Net Assets of £-2.7m and 1.87x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Nupharm Laboratories Limited Overview
Nupharm Laboratories Limited is a dissolved company that was located in newcastle upon tyne, NE3 3LS with a Companies House number of 04123795. It operated in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in December 2000, it's largest shareholder was nupharm group ltd with a 100% stake. The last turnover for Nupharm Laboratories Limited was estimated at £2.5m.
Upgrade for unlimited company reports & a free credit check
Nupharm Laboratories Limited Health Check
Pomanda's financial health check has awarded Nupharm Laboratories Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 8 areas for improvement. Company Health Check FAQs
4 Strong
0 Regular
8 Weak
Size
annual sales of £2.5m, make it smaller than the average company (£25.6m)
£2.5m - Nupharm Laboratories Limited
£25.6m - Industry AVG
Growth
3 year (CAGR) sales growth of -17%, show it is growing at a slower rate (5.9%)
- Nupharm Laboratories Limited
5.9% - Industry AVG
Production
with a gross margin of 28.3%, this company has a higher cost of product (40.8%)
28.3% - Nupharm Laboratories Limited
40.8% - Industry AVG
Profitability
an operating margin of -132.2% make it less profitable than the average company (9%)
-132.2% - Nupharm Laboratories Limited
9% - Industry AVG
Employees
with 59 employees, this is below the industry average (114)
59 - Nupharm Laboratories Limited
114 - Industry AVG
Pay Structure
on an average salary of £24.2k, the company has a lower pay structure (£44.2k)
£24.2k - Nupharm Laboratories Limited
£44.2k - Industry AVG
Efficiency
resulting in sales per employee of £42.5k, this is less efficient (£233.5k)
£42.5k - Nupharm Laboratories Limited
£233.5k - Industry AVG
Debtor Days
it gets paid by customers after 20 days, this is earlier than average (56 days)
20 days - Nupharm Laboratories Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 55 days, this is slower than average (41 days)
55 days - Nupharm Laboratories Limited
41 days - Industry AVG
Stock Days
it holds stock equivalent to 50 days, this is less than average (81 days)
50 days - Nupharm Laboratories Limited
81 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (9 weeks)
0 weeks - Nupharm Laboratories Limited
9 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 361.5%, this is a higher level of debt than the average (51.1%)
361.5% - Nupharm Laboratories Limited
51.1% - Industry AVG
NUPHARM LABORATORIES LIMITED financials
Nupharm Laboratories Limited's latest turnover from January 2016 is £2.5 million and the company has net assets of -£2.7 million. According to their latest financial statements, Nupharm Laboratories Limited has 59 employees and maintains cash reserves of £35.4 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jan 2016 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|
| Turnover | 2,509,948 | 3,890,415 | |||||
| Other Income Or Grants | |||||||
| Cost Of Sales | 1,799,526 | 2,202,503 | |||||
| Gross Profit | 710,422 | 1,687,912 | |||||
| Admin Expenses | 4,027,585 | 1,034,731 | |||||
| Operating Profit | -3,317,163 | 653,181 | |||||
| Interest Payable | 200,005 | 18,000 | |||||
| Interest Receivable | 5,552 | ||||||
| Pre-Tax Profit | -3,331,616 | 635,181 | |||||
| Tax | 127,697 | 31,180 | |||||
| Profit After Tax | -3,203,919 | 666,361 | |||||
| Dividends Paid | 320,000 | 550,000 | |||||
| Retained Profit | -3,523,919 | 116,361 | |||||
| Employee Costs | 1,428,456 | 1,421,899 | |||||
| Number Of Employees | 59 | 59 | |||||
| EBITDA* | -3,077,682 | 847,690 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jan 2016 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|
| Tangible Assets | 744,538 | 725,669 | 793,775 | 694,273 | 565,175 | 518,073 | |
| Intangible Assets | |||||||
| Investments & Other | |||||||
| Debtors (Due After 1 year) | |||||||
| Total Fixed Assets | 744,538 | 725,669 | 793,775 | 694,273 | 565,175 | 518,073 | |
| Stock & work in progress | 251,147 | 224,852 | 198,595 | 175,274 | 144,104 | 105,435 | 106,988 |
| Trade Debtors | 140,057 | 560,890 | 784,622 | 539,324 | 361,977 | 354,473 | 268,243 |
| Group Debtors | 352,982 | ||||||
| Misc Debtors | 68,371 | 169,894 | |||||
| Cash | 35,391 | 96,248 | 4,365 | 65,693 | |||
| misc current assets | 553,930 | ||||||
| total current assets | 1,048,896 | 1,308,618 | 1,079,465 | 718,963 | 571,774 | 459,908 | 375,231 |
| total assets | 1,048,896 | 2,053,156 | 1,805,134 | 1,512,738 | 1,266,047 | 1,025,083 | 893,304 |
| Bank overdraft | 3,466 | ||||||
| Bank loan | |||||||
| Trade Creditors | 272,715 | 342,343 | 1,023,495 | 806,312 | 698,530 | 677,727 | 710,857 |
| Group/Directors Accounts | 1,835,020 | 140,379 | |||||
| other short term finances | 12,900 | ||||||
| hp & lease commitments | 32,535 | 50,816 | |||||
| other current liabilities | 1,651,667 | 613,280 | |||||
| total current liabilities | 3,791,937 | 1,163,184 | 1,023,495 | 806,312 | 698,530 | 677,727 | 710,857 |
| loans | 6,343 | ||||||
| hp & lease commitments | 32,302 | ||||||
| Accruals and Deferred Income | |||||||
| other liabilities | 62,451 | 190,609 | 226,663 | 69,930 | 78,124 | ||
| provisions | 64,897 | 89,679 | 99,240 | 95,293 | |||
| total long term liabilities | 103,542 | 152,130 | 289,849 | 321,956 | 69,930 | 78,124 | |
| total liabilities | 3,791,937 | 1,266,726 | 1,175,625 | 1,096,161 | 1,020,486 | 747,657 | 788,981 |
| net assets | -2,743,041 | 786,430 | 629,509 | 416,577 | 245,561 | 277,426 | 104,323 |
| total shareholders funds | -2,743,041 | 786,430 | 629,509 | 416,577 | 245,561 | 277,426 | 104,323 |
| Jan 2016 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Profit | -3,317,163 | 653,181 | |||||
| Depreciation | 239,481 | 194,509 | 143,795 | 155,327 | 145,831 | 88,124 | 86,554 |
| Amortisation | |||||||
| Tax | 127,697 | 31,180 | |||||
| Stock | 251,147 | 26,257 | 23,321 | 31,170 | 38,669 | -1,553 | 106,988 |
| Debtors | 208,428 | 299,144 | 245,298 | 177,347 | 7,504 | 86,230 | 268,243 |
| Creditors | 272,715 | -681,152 | 217,183 | 107,782 | 20,803 | -33,130 | 710,857 |
| Accruals and Deferred Income | 1,651,667 | 613,280 | |||||
| Deferred Taxes & Provisions | -24,782 | -9,561 | 3,947 | 95,293 | |||
| Cash flow from operations | -1,485,178 | 460,815 | |||||
| Investing Activities | |||||||
| capital expenditure | |||||||
| Change in Investments | |||||||
| cash flow from investments | |||||||
| Financing Activities | |||||||
| Bank loans | |||||||
| Group/Directors Accounts | 1,835,020 | 140,379 | |||||
| Other Short Term Loans | 12,900 | ||||||
| Long term loans | 6,343 | ||||||
| Hire Purchase and Lease Commitments | 32,535 | 83,118 | |||||
| other long term liabilities | -62,451 | -128,158 | -36,054 | 156,733 | -8,194 | 78,124 | |
| share issue | |||||||
| interest | -194,453 | -18,000 | |||||
| cash flow from financing | 2,453,980 | 202,849 | |||||
| cash and cash equivalents | |||||||
| cash | 35,391 | -96,248 | 91,883 | -61,328 | 65,693 | ||
| overdraft | 3,466 | ||||||
| change in cash | 35,391 | -99,714 | 91,883 | -61,328 | 65,693 |
nupharm laboratories limited Credit Report and Business Information
Nupharm Laboratories Limited Competitor Analysis
Perform a competitor analysis for nupharm laboratories limited by selecting its closest rivals, whether from the MANUFACTURING sector, other undefined companies, companies in NE3 area or any other competitors across 12 key performance metrics.
nupharm laboratories limited Ownership
NUPHARM LABORATORIES LIMITED group structure
Nupharm Laboratories Limited has no subsidiary companies.
Ultimate parent company
2 parents
NUPHARM LABORATORIES LIMITED
04123795
nupharm laboratories limited directors
Nupharm Laboratories Limited currently has 2 directors. The longest serving directors include Mr Andrew Matthews (Aug 2015) and Mr David Sanson (Sep 2015).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Andrew Matthews | 48 years | Aug 2015 | - | Director | |
| Mr David Sanson | 65 years | Sep 2015 | - | Director |
P&L
January 2016turnover
2.5m
0%
operating profit
-3.3m
0%
gross margin
28.4%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2016net assets
-2.7m
0%
total assets
1m
0%
cash
35.4k
0%
net assets
Total assets minus all liabilities
nupharm laboratories limited company details
company number
04123795
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
21200 - Manufacture of pharmaceutical preparations
incorporation date
December 2000
age
25
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
January 2016
previous names
pharma formulation services limited (February 2001)
accountant
-
auditor
-
address
bulman house regent centre, gosforth, newcastle upon tyne, NE3 3LS
Bank
-
Legal Advisor
-
nupharm laboratories limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 8 charges/mortgages relating to nupharm laboratories limited. Currently there are 0 open charges and 8 have been satisfied in the past.
nupharm laboratories limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NUPHARM LABORATORIES LIMITED. This can take several minutes, an email will notify you when this has completed.
nupharm laboratories limited Companies House Filings - See Documents
| date | description | view/download |
|---|
